We are happy to join forces with the industry leaders working to better mRNA medicines, increase their accessibility, and educate patients and their families about mRNA and how it works in therapies and vaccines.
prof. Dominika Nowis, our Director of Biology, will join AMM’s Board of Directors to work with partners from other companies, academia, and government representatives on key challenges for the field.
We are looking forward to actively participating in AMM’s efforts and events.